Skip to main content

Published locations for Lebrikizumab gets European nod for treating moderate-to-severe atopic dermatitis

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Lebrikizumab gets European nod for treating moderate-to-severe atopic dermatitis

User login

  • Reset your password
  • /content/lebrikizumab-gets-european-nod-treating-moderate-severe-atopic-dermatitis
  • /edermatologynews/article/266642/atopic-dermatitis/lebrikizumab-gets-european-nod-treating-moderate
  • /familypracticenews/article/266642/atopic-dermatitis/lebrikizumab-gets-european-nod-treating-moderate
  • /internalmedicinenews/article/266642/atopic-dermatitis/lebrikizumab-gets-european-nod-treating
  • /pediatricnews/article/266642/atopic-dermatitis/lebrikizumab-gets-european-nod-treating-moderate
  • /pediatrics/article/266642/atopic-dermatitis/lebrikizumab-gets-european-nod-treating-moderate-severe
  • /internalmedicine/article/266642/atopic-dermatitis/lebrikizumab-gets-european-nod-treating-moderate
  • /dermatology/article/266642/atopic-dermatitis/lebrikizumab-gets-european-nod-treating-moderate-severe
  • /familymedicine/article/266642/atopic-dermatitis/lebrikizumab-gets-european-nod-treating-moderate